Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price hits fresh 52-week high; stock closes lower
- August 25, 2026
- Posted by: Harsh Piplani
- Category: News
Akums Drugs & Pharmaceuticals Share Price was Rs 765.50 on 25 August 2026, down 0.60% from the previous close of Rs 770.15, after touching a fresh 52-week high of Rs 783.80. The company’s market capitalisation stood at Rs 11,804.55 crore. The event matters because the stock printed a yearly high in today’s session, even though it ended below that level by the close.
Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 765.5 |
| Previous Close | Rs 770.15 |
| Today's Move | Rs -4.65 (-0.6%) |
| Open | Rs 783.05 |
| High | Rs 783.8 |
| Low | Rs 764.9 |
| Turnover | Rs 0.51 crore |
| Market Capitalisation | Rs 11,804.55 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 765.5 versus the previous close of Rs 770.15, a fall of 0.6%. The stock opened at Rs 783.05, reached a high of Rs 783.8 and touched a low of Rs 764.9.
Akums Drugs & Pharmaceuticals Share Price Today moved between Rs 783.05 and Rs 764.90 after setting a fresh 52-week high at Rs 783.80. The stock closed at Rs 765.50, which was Rs 4.65 lower than the previous close of Rs 770.15, or 0.60% down on the day. That means the close finished Rs 18.30 below the session high and Rs 18.15 above the session low.
For readers tracking Akums Drugs & Pharmaceuticals Share Price Live, the important fact is that the one-year high was established in the same session and then the stock settled lower than that peak. On a straightforward arithmetic basis, the closing price was 2.34% below the day’s high of Rs 783.80. Univest treats that as a price-event report: it confirms the fresh 52-week high, the closing level and the intraday range, but it does not assign a company-specific reason beyond the supplied data. That makes this Akums Drugs & Pharmaceuticals Share Price move useful for Akums Drugs & Pharmaceuticals Stock Analysis and for anyone scanning Akums Drugs & Pharmaceuticals Share News on the Indian Stock Market.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 11,804.55 crore |
| P/E Ratio | 41.55x |
| P/B Ratio | 3.55x |
| ROE | 8.06% |
| ROCE | 14.77% |
| EPS | Rs 18.53 |
| Book Value Per Share | Rs 216.98 |
| Dividend Yield | 0.39% |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 41.55x, P/B 3.55x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 11804.55 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.55x, P/B at 3.55x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.39%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.49x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 41.55x |
| Benchmark Median P/E | 30.49x |
| Benchmark Average P/E | 46.74x |
| Benchmark P/E Range | 2.94x to 717.43x |
| Company P/B Ratio | 3.55x |
| Benchmark Median P/B | 2.67x |
| Company ROE | 8.06% |
| Benchmark Median ROE | 11.83% |
| Company ROCE | 14.77% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 11,804.55 crore |
| Benchmark Median Market Cap | Rs 575.35 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.55x, which is above the benchmark median of 30.49x, a difference of +36.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.83%, a difference of -31.87%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.75%, a difference of +7.42%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sequent Scientific Ltd. | VIYASH | 12,152.45 | 70.1 | 4.27 | 9.06 | 13.1 |
| Blue Jet Healthcare Ltd. | BLUEJET | 11,282.72 | 47.47 | 4.98 | 19.88 | 27.18 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 12,549.72 | 70.01 | 13.84 | 25.37 | 28.5 |
| CORONA Remedies Ltd. | CORONA | 13,087.65 | 65.95 | 16.27 | 27.36 | 31.74 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 14,003.2 | 40.84 | 2.02 | 5.97 | 8.69 |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 41.55x compared with the displayed peer median of 65.95x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 11,804.55 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals
- The stock touched a fresh 52-week high of Rs 783.80 in today’s session.
- The closing price was Rs 765.50, below the day’s high and below the previous close of Rs 770.15.
- Market capitalisation stood at Rs 11,804.55 crore.
- P/E was 41.55, P/B was 3.55, ROE was 8.06% and ROCE was 14.77%.
- Revenue in Jun 2026 was Rs 11,666.29 crore and net profit was Rs 1,000.10 crore.
About Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data tracks its stock on NSE and BSE, and the financial record available here includes market capitalisation, valuation ratios, earnings per share, book value and quarterly revenue and profit figures. Univest uses this company profile to place the Akums Drugs & Pharmaceuticals Share Price event into a broader research context for Akums Drugs & Pharmaceuticals Latest News and Akums Drugs & Pharmaceuticals Company News.
Track Akums Drugs & Pharmaceuticals Share Price on Univest
Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, valuation ratios, shareholding pattern, company financials, market cap, and sector comparison. Univest also presents stock-level context so users can follow Akums Drugs & Pharmaceuticals Share Price Today alongside related Akums Drugs & Pharmaceuticals Stock News.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Akums Drugs & Pharmaceuticals Share Price today?
Ans. Akums Drugs & Pharmaceuticals Share Price was Rs 765.50 at the close, down 0.60% from the previous close of Rs 770.15. The stock had touched a fresh 52-week high of Rs 783.80 in the same session.
Did Akums Drugs & Pharmaceuticals hit a fresh 52-week high?
Ans. Yes. Akums Drugs & Pharmaceuticals Share Price touched a fresh 52-week high of Rs 783.80. The session then ended lower at Rs 765.50, but the yearly high event was still established in today’s trade.
What does the price action show for Akums Drugs & Pharmaceuticals Share Price?
Ans. The day’s range was Rs 764.90 to Rs 783.80, with the open at Rs 783.05 and the close at Rs 765.50. That shows the stock moved through a wide intraday band before settling lower.
What is the market capitalisation of Akums Drugs & Pharmaceuticals?
Ans. Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 11,804.55 crore. In the supplied sector benchmark, that is above the median industry market cap of Rs 575.35 crore and below the average of Rs 13,752.40 crore.
How is Akums Drugs & Pharmaceuticals valued against the sector?
Ans. Akums Drugs & Pharmaceuticals Share Price is backed by a P/E of 41.55 and a P/B of 3.55. Both sit above the sector medians of 30.49 and 2.67 respectively, while ROCE of 14.77% is above the sector median.
What are the EPS and book value for Akums Drugs & Pharmaceuticals?
Ans. EPS is Rs 18.53 and book value is Rs 216.98. These two figures help frame the Akums Drugs & Pharmaceuticals Share Price because EPS reflects earnings per share while book value shows accounting net worth per share.
What is the dividend yield for Akums Drugs & Pharmaceuticals?
Ans. The dividend yield is 0.39%. That is historical and current data linked to the Akums Drugs & Pharmaceuticals Share Price, so it should be read alongside valuation, profitability and quarterly financial performance.
How does Akums Drugs & Pharmaceuticals compare with peers?
Ans. In the supplied peer set, Akums Drugs & Pharmaceuticals Share Price sits with companies that show a wide range of P/E, P/B, ROE and ROCE. Akums is above Jubilant Pharmova on ROCE and below several peers on ROE.
